FLT3 and acute myeloid leukemia: AML patients with high AR FLT3-ITD had significantly low complete remission (CR) rates, with poor survival and relapse; only high FLT3-ITD AR patients (≥0.5) benefited from allogeneic stem cell transplantation (32).